HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS)

Authors

  • Narmeen Rizgar Muhammed Khalil University of Duhok College of Science Department of Biology
  • Ali Abdul Hussein Mohammed Nasser University of Karbala College of Science Department of Biology
  • Anwar Mohammed Jabbar Nasr University of Basra College of Sciences Biology Department
  • Maysaa Bakr Hamdi Jawad University of Baghdad College of Science Department of Biology
  • Ali Khaled Darwish Hamody University of Diayla College of Science/ Department of Biology

Abstract

Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare hereditary fatal disease in newborn babies, HGPS is caused by mutations in LMNA that result in the production of an abnormal form of lamin A termed progerin. This genetic disease is very rare that the estimated incidence of HGPS in the USA is one in eight million births, based on the number of cases. Doctors and researchers say that the cause of death of these children is due to health problem, such as heart problem, veins and strokes. Doctors confirm that premature aging has nothing to do with the death of children with the rare disease (progeria). Currently, researchers and doctors are trying to understand premature aging and determine treatment options. Some areas of research include: Study genes and the course of disease to understand how it develops. This may help identify new treatments. Study of methods of preventing cardiovascular disease. Conducting human clinical trials with drugs that may be effective for treating premature aging. Testing other drugs to treat premature aging.

Downloads

Published

2024-07-23

How to Cite

Narmeen Rizgar Muhammed Khalil, Ali Abdul Hussein Mohammed Nasser, Anwar Mohammed Jabbar Nasr, Maysaa Bakr Hamdi Jawad, & Ali Khaled Darwish Hamody. (2024). HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS). Intent Research Scientific Journal, 3(7), 38–56. Retrieved from https://intentresearch.org/index.php/irsj/article/view/334

Issue

Vol. 3 No. 7 (2024): IRSJ

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.